Cohort study on traditional Chinese medicine for interstitial lung disease
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Interstitial Lung Disease (RESEARCH-ILD)
This study is testing whether traditional Chinese medicine can help people with interstitial lung disease feel better and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Henan University of Traditional Chinese Medicine Academic / other |
| Locations | 1 site (Zhengzhou, Henan) |
| Trial ID | NCT06577753 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze the effects of traditional Chinese medicine (TCM) on patients with interstitial lung disease (ILD) in China. It will include at least 5000 ILD patients who will be followed for a minimum of five years. Participants will be divided into two cohorts: one receiving TCM treatment and the other not. The study will assess various factors including demographic characteristics, clinical features, disease progression, and the efficacy of TCM in managing ILD symptoms and improving quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with interstitial lung disease.
Not a fit: Patients with acute ILD caused by known reasons that resolve within two weeks after treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the effectiveness of traditional Chinese medicine in treating interstitial lung disease, potentially improving patient outcomes.
How similar studies have performed: While traditional Chinese medicine has been explored in various contexts, this specific cohort study focusing on ILD is novel and has not been extensively tested in previous studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients who meet the diagnosis of ILD; 2. Age≥18 years old; 3. Ability to provide independent informed consent. Exclusion Criteria: Patients with acute ILD caused by known reasons, but the lesions disappear within 2 weeks after treatment. Example: Interstitial pneumonia caused by infections such as mycoplasma/virus, and those who recover after treatment are excluded.
Where this trial is running
Zhengzhou, Henan
- The First Affiliated Hospital of Henan University of Chinese Medicine — Zhengzhou, Henan, China (Recruiting)
Study contacts
- Study coordinator: Xue-qing Yu, Ph.D
- Email: yxqshi@163.com
- Phone: +8613525518843
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.